The Fall 2017 Forum includes protocols for co-prescribing naloxone, Board member appointments, Dr. Eleanor E. Greene discussing the Board making public outreach a priority in her final President’s Message, five questions with Board Member Dr. Venkata Jonnalagadda, a new column in the Forum from NCPHP called Wellspring, a Q&A on licensee obligation to complete death certificates, and a timeline of the PA profession which celebrates 50 years of serving patients.
The Summer 2017 Forum includes a “quick start” guide to the STOP Act of 2017, addressing burnout from a doctor’s perspective, a Message From the President from Dr. Greene discussing caring for pain patients in the midst of mounting opioids regulation, five questions with Board Member Ralph W. Walker, JD, an article on revised opioids investigative criteria now in effect, and a call for panelists to participate in statewide series of panel discussions on responsible opioid prescribing practices.
The Spring 2017 Forum includes the 2016 Year in Review, information about the proposed Use of Photography in the Examination Room position statement, an article about Medicare’s new Quality Payment Program, a Message From the President from Dr. Greene discussing the new controlled substances CME requirement, five questions with Board Member Dr. Bryant Murphy, and a call for applicants to serve on the Board.
The winter 2017 Forum includes Dr. Greene’s first Message from the President, a review of changes made to Position Statements in 2016, an infographic detailing the results of the licensee survey, an overview of proposed changes to the Safe Opioid Prescribing Initiative, and information on how to find course to satisfy the new CME requirement.
This issue of the Forum includes Dr. Udekwu’s final message as Board president, information on the new and reappointed Board Members, an infographic showing the current data from the Safe Opioid Prescribing Initiative (SOPI), an update on the Board’s preliminary move to adopt the CDC’s opioid policy, and an article on the Board’s new approach to monitoring licensee health issues.